This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Lille, Inserm (Institute National De La Santa Et De La Recherche Medicale), Instiut Pasteur De Lille. Active years: 2026.
Company Filing History:
1 out of 26 
1 out of 1 
1 out of 1 
Years Active: 2026
Title: Mickael Rosa: Innovator in Aortic Valve Calcification Research
Introduction
Mickael Rosa is a notable inventor based in Lille, France. He has made significant contributions to the field of medical research, particularly in understanding and addressing aortic valve calcification. His innovative work has led to the development of a patent that holds promise for improving heart health.
Latest Patents
Mickael Rosa holds a patent for the "Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve." Aortic valve calcification is a condition characterized by calcium deposits forming on the aortic valve in the heart. These deposits can lead to narrowing of the valve opening, resulting in a condition known as aortic valve stenosis. Rosa's research demonstrates that retinoic acid can decrease calcification and the osteoblast-like phenotype in valvular interstitial cells (VICs). More specifically, RARα activation has been shown to reduce calcification and the osteoblast-like phenotype in VICs. Conversely, inhibiting ALDH1A1 increases calcification and the osteoblast-like phenotype in VICs. These findings suggest that RAR agonists could be effective in reversing, preventing, or delaying aortic valve calcification.
Career Highlights
Throughout his career, Mickael Rosa has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Lille. His research has focused on innovative solutions to complex medical issues, particularly those affecting cardiovascular health.
Collaborations
Mickael Rosa has collaborated with notable colleagues, including Sophie Susen and Delphine Corseaux. These partnerships have contributed to the advancement of his research and the development of his patent.
Conclusion
Mickael Rosa's work in the field of aortic valve calcification represents a significant advancement in medical research. His innovative approach and patented solutions have the potential to improve treatment options for patients suffering from this condition.